Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial-Reference-Cited by-同舟云学术

Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial

Published:2009-08 Issue:8 Volume:10 Page:785-793
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Stupp Roger,Mayer Michael,Kann Roger,Weder Walter,Zouhair Abderahim,Betticher Daniel C,Roth Arnaud D,Stahel Rolf A,Majno Sabine Balmer,Peters Solange,Jost Lorenz,Furrer Markus,Thierstein Sandra,Schmid Ralph A,Hsu-Schmitz Shu-Fang,Mirimanoff René-Olivier,Ris Hans-Beat,Pless Miklos

Publisher

Elsevier BV

Subject

Oncology

Reference49 articles.

1. Definitive chemoradiation for the treatment of locally advanced non small-cell lung cancer;Blackstock;J Clin Oncol,2007

2. Current treatment paradigms for locally advanced non-small cell lung cancer;Rigas;J Thorac Oncol,2007

3. Revisions in the international system for staging lung cancer;Mountain;Chest,1997

4. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial;Dillman;J Natl Cancer Inst,1996

5. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 Study;Fournel;J Clin Oncol,2005

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Five-year follow-up of neoadjuvant PD-1 inhibitor (sintilimab) in non-small cell lung cancer;Journal for ImmunoTherapy of Cancer;2024-08

2. Surgery patterns and survival of T4N2 non-small cell lung cancer – A population-based analysis;Clinical Surgical Oncology;2024-03

3. Efficacy and safety of neoadjuvant immunotherapy protocols and cycles for non-small cell lung cancer: a systematic review and meta-analysis;Frontiers in Oncology;2024-01-16

4. Evaluation of the efficacy and surgical-related safety of neoadjuvant immunochemotherapy in advanced resectable none small cell lung cancer (NSCLC);Frontiers in Oncology;2023-12-22

5. Survival Effect of Surgery in Patients with Stage IIIB/N2 Non-small Cell Lung Cancer: A Comparative Study with Definitive Chemoradiotherapy;Thoracic Research and Practice;2023-11-28